Table 4.
Values | B | SE (B) | Wald X2 | P | OR | 95% CI |
---|---|---|---|---|---|---|
Age | 0.073 | 0.035 | 4.367 | 0.037 | 1.076 | 1.005–1.152 |
Sex | −0.545 | 1.157 | 0.222 | 0.637 | 0.58 | 0.06–5.601 |
Read Number | −2.371 | 0.599 | 15.677 | 0.000 | 0.093 | 0.029–0.302 |
HOD | −0.028 | 0.061 | 0.216 | 0.642 | 0.972 | 0.863–1.095 |
Survival Time | −0.007 | 0.005 | 1.888 | 0.169 | 0.993 | 0.983–1.003 |
Cytokines pg/ml | ||||||
IL-2 | 0.171 | 1.115 | 0.023 | 0.878 | 1.186 | 0.133–10.553 |
IL-4 | −1.299 | 0.893 | 2.116 | 0.146 | 0.273 | 0.047–1.57 |
IL-6 | −0.005 | 0.019 | 0.077 | 0.781 | 0.995 | 0.957–1.033 |
TNF-α | −0.374 | 0.373 | 1.003 | 0.316 | 0.688 | 0.331–1.430 |
IL-17a | 0.202 | 0.137 | 2.165 | 0.141 | 1.223 | 0.935–1.6 |
IL-10 | −2.64 | 0.206 | 1.639 | 0.201 | 0.768 | 0.513–1.151 |
IFN-γ | 0.09 | 0.071 | 1.606 | 0.205 | 1.095 | 0.952–1.259 |
Cellular Immunity % | ||||||
CD4/CD8 | −0.488 | 0.965 | 0.256 | 0.613 | 0.614 | 0.093–4.067 |
Th cell | 0.318 | 0.296 | 1.151 | 0.283 | 1.374 | 0.769–2.454 |
Ts cell | 0.244 | 0.317 | 0.589 | 0.443 | 1.276 | 0.685–2.377 |
NK cell | −0.223 | 0.211 | 1.121 | 0.29 | 0.800 | 0.529–1.209 |
B cell | −0.26- | 0.245 | 1.172 | 0.279 | 0.767 | 0.227–1.475 |
T cell | 0.5485 | 0.478 | 1.315 | 0.252 | 0.578 | 0.475–1.239 |
WBC ×109 | −0.123 | 1.228 | 0.01 | 0.92 | 0.884 | 0.08–9.819 |
Neu×109 | 0.141 | 1.39 | 0.01 | 0.919 | 1.151 | 0.076–17.535 |
PCT ng/ml | −0.681 | 1.514 | 0.202 | 0.653 | 0.506 | 0.026–9.844 |
CRP mg/l | −0.004 | 0.015 | 0.073 | 0.788 | 0.996 | 0.968–1.025 |
Abbreviations: HOD hospital day, WBC white blood cells, IL- interleukin-, IFN-γ Interferon-γ, TNF-α Tumor Necrosis Factor-α, CD4 Cluster of Differentiation 4 receptors, CD8 Cluster of Differentiation 8 receptors, Th helper T cell, Ts suppressor T cell, NK natural killer cell, Neu neutrophil, PCT procalcitonin, CRP C-reactive protein